Advertisement
Advertisement

CSBR

CSBR logo

Champions Oncology, Inc.

6.76
USD
Sponsored
+0.23
+3.58%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

6.88

+0.12
+1.79%

CSBR Earnings Reports

Positive Surprise Ratio

CSBR beat 17 of 31 last estimates.

55%

Next Report

Date of Next Report
Mar 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$16.95M
/
$0.09
Implied change from Q2 26 (Revenue/ EPS)
+12.67%
/
+350.00%
Implied change from Q3 25 (Revenue/ EPS)
-0.55%
/
-75.00%

Champions Oncology, Inc. earnings per share and revenue

On Dec 15, 2025, CSBR reported earnings of 0.02 USD per share (EPS) for Q2 26, beating the estimate of 0.01 USD, resulting in a 96.08% surprise. Revenue reached 15.04 million, compared to an expected 14.32 million, with a 5.01% difference. The market reacted with a -13.72% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of 0.09 USD, with revenue projected to reach 16.95 million USD, implying an increase of 350.00% EPS, and increase of 12.67% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q2 2026, Champions Oncology, Inc. reported EPS of $0.02, beating estimates by 96.08%, and revenue of $15.04M, 5.01% above expectations.
The stock price moved down -13.72%, changed from $7.80 before the earnings release to $6.73 the day after.
The next earning report is scheduled for Mar 09, 2026.
Based on 3 analysts, Champions Oncology, Inc. is expected to report EPS of $0.09 and revenue of $16.95M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement